DK0857725T3 - (N-(pyridinylmethyl)-heterocyklisk)ylidenamin-forbindelser som nicotinacetylcholinreceptor-bindemidler - Google Patents

(N-(pyridinylmethyl)-heterocyklisk)ylidenamin-forbindelser som nicotinacetylcholinreceptor-bindemidler

Info

Publication number
DK0857725T3
DK0857725T3 DK97309220T DK97309220T DK0857725T3 DK 0857725 T3 DK0857725 T3 DK 0857725T3 DK 97309220 T DK97309220 T DK 97309220T DK 97309220 T DK97309220 T DK 97309220T DK 0857725 T3 DK0857725 T3 DK 0857725T3
Authority
DK
Denmark
Prior art keywords
pyridinylmethyl
heterocyclic
compounds
ylidenamine
acetylcholine receptor
Prior art date
Application number
DK97309220T
Other languages
Danish (da)
English (en)
Inventor
Peter Hans Dorff
Stanley Jung
Steven Wayne Goldstein
Arthur Adam Nagel
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0857725T3 publication Critical patent/DK0857725T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
DK97309220T 1997-02-06 1997-11-17 (N-(pyridinylmethyl)-heterocyklisk)ylidenamin-forbindelser som nicotinacetylcholinreceptor-bindemidler DK0857725T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3803697P 1997-02-06 1997-02-06

Publications (1)

Publication Number Publication Date
DK0857725T3 true DK0857725T3 (da) 2001-09-24

Family

ID=21897750

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97309220T DK0857725T3 (da) 1997-02-06 1997-11-17 (N-(pyridinylmethyl)-heterocyklisk)ylidenamin-forbindelser som nicotinacetylcholinreceptor-bindemidler

Country Status (10)

Country Link
US (1) US6020335A (fr)
EP (1) EP0857725B1 (fr)
JP (2) JP3542893B2 (fr)
AT (1) ATE203535T1 (fr)
CA (1) CA2220438C (fr)
DE (1) DE69705817T2 (fr)
DK (1) DK0857725T3 (fr)
ES (1) ES2159380T3 (fr)
GR (1) GR3036626T3 (fr)
PT (1) PT857725E (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2366260A1 (fr) * 1999-03-05 2000-09-14 Masahiro Imoto Composes heterocycliques possedant un effet d'activation du recepteur .alpha.4.beta.2 de l'acetylcholine nicotinique
JP2001302635A (ja) * 2000-04-21 2001-10-31 Suntory Ltd 新規複素環化合物
ATE315555T1 (de) * 2001-05-11 2006-02-15 Pfizer Prod Inc Thiazolderivate und ihre verwendung als cdk- inhibitoren
US20030134844A1 (en) * 2001-10-31 2003-07-17 Pfizer Inc. Nicontinic acetylcholine receptor antagonists in the treatment of restless legs syndrome
IL160967A0 (en) * 2001-10-31 2004-08-31 Pfizer Prod Inc Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
CN1596263A (zh) 2001-11-30 2005-03-16 辉瑞产品公司 芳基－稠合的氮杂多环化合物
US20030162770A1 (en) 2002-02-22 2003-08-28 Davis Bonnie M. Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
CA2529193A1 (fr) 2003-07-21 2005-01-27 Pfizer Products Inc. Composes azapolycycliques fusionnes avec heteroaryle pour reduire la dependance a la nicotine
WO2006006071A1 (fr) * 2004-07-07 2006-01-19 Pfizer Products Inc. Resolution de compose azapolycyclique fusionne aryle
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
DK1951663T3 (en) 2005-11-24 2016-10-10 Dompé Farm S P A (r)-arylkylaminoderivater og farmaceutiske sammensætninger indeholdende dem
ES2521494T3 (es) 2007-04-02 2014-11-12 Parkinson's Institute Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
US20100233503A1 (en) * 2009-03-13 2010-09-16 Zachman Joseph M Panel for a storage container
WO2014078568A1 (fr) 2012-11-14 2014-05-22 The Johns Hopkins University Méthodes et compositions pour le traitement de la schizophrénie
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
WO2018129304A1 (fr) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Dispositifs et methodes d'administration transdermique de medicament
EP3801732A4 (fr) 2018-05-29 2022-04-27 Morningside Venture Investments Limited Procédés et systèmes d'administration de médicament
JP2022507660A (ja) 2018-11-16 2022-01-18 モーニングサイド ベンチャー インベストメンツ リミテッド 温度によって調節される経皮薬剤送達システム

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6230780A (ja) * 1985-04-17 1987-02-09 Ss Pharmaceut Co Ltd １，７−ナフチリジン誘導体及びこれを含有する薬剤
US5814645A (en) * 1993-03-24 1998-09-29 Bayer Aktiengesellschaft Arylor hetaryl substituted nitrogen heterocycles and their use as pesticides
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten

Also Published As

Publication number Publication date
MX9709164A (es) 1998-09-30
ES2159380T3 (es) 2001-10-01
EP0857725B1 (fr) 2001-07-25
CA2220438A1 (fr) 1998-08-06
US6020335A (en) 2000-02-01
PT857725E (pt) 2001-11-30
JP2004175809A (ja) 2004-06-24
JP3542893B2 (ja) 2004-07-14
JPH10226684A (ja) 1998-08-25
DE69705817T2 (de) 2001-11-08
DE69705817D1 (de) 2001-08-30
CA2220438C (fr) 2005-08-16
GR3036626T3 (en) 2001-12-31
EP0857725A1 (fr) 1998-08-12
ATE203535T1 (de) 2001-08-15

Similar Documents

Publication Publication Date Title
DK0857725T3 (da) (N-(pyridinylmethyl)-heterocyklisk)ylidenamin-forbindelser som nicotinacetylcholinreceptor-bindemidler
WO2002016357A3 (fr) Composes aryle substitues par quinuclidine destines au traitement de maladies
WO2002016358A3 (fr) Composes aryliques substitues par quinuclidine destines au traitement de maladies
PL365163A1 (en) Aryl fused azapolycyclic compounds
ATE180780T1 (de) 2-(piperidin-4-yl, pyridin-4-yl und tetrahydropyridin-4-yl)-benzofuran-7-carbamat derivate, ihre herstellung und verwendung als acetylcholinesterase inhibitoren
FI102069B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi
JP2003513071A5 (fr)
ATE202354T1 (de) Tetracyclische kondensierte heterocyclische verbindungen zur behandlung von seniler demenz
WO2004022540A3 (fr) Compose de pyridazinone et son utilisation pharmaceutique
AU1485292A (en) 1-(pyrido(3,4.b)-1,4-oxazinyl-4-yl)-1h-indoles, intermediates and a process for their preparation, and their use as medicaments
GR3025318T3 (en) Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments
WO2008092877A3 (fr) Inhibiteurs du transporteur glyt1 et leurs utilisations dans le traitement de troubles neurologiques et neuropsychiatriques
GR3034499T3 (en) Optically active imidazolidinone derivative and process for producing the same
DK1254905T3 (da) 4-(2-pyridyl)piperiziner med 5HT7 receptoragonistaktivitet
EP1034783A4 (fr) Derives d'amide
TW200714282A (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
NZ334553A (en) N-(2-Benzothiazolyl) piperidine-1 ethanamine derivatives and pharmaceutical use
GR3024187T3 (en) Tetrahydrocyclopent[b]indole methanamines and related compounds, a process for their preparation and their use as medicaments.
AU633791B2 (en) 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
JP2003513072A5 (fr)
GR3017801T3 (en) Flavone derivatives.
WO2007080159A3 (fr) Composés actifs au niveau du transporteur de glycine glyt1 et utilisations
HU912674D0 (en) Derivatives of 1-(pyridyl-alkyl)-1h-indole or -indole and process for producing said compounds